158 related articles for article (PubMed ID: 33646503)
21. The Societal Costs of Schizophrenia in Switzerland.
Pletscher M; Mattli R; von Wyl A; Reich O; Wieser S
J Ment Health Policy Econ; 2015 Jun; 18(2):93-103. PubMed ID: 26231000
[TBL] [Abstract][Full Text] [Related]
22. Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.
Goonewardene SS; Persad R; Young A; Makar A
Eur Urol; 2014 Sep; 66(3):e51-2. PubMed ID: 24813269
[No Abstract] [Full Text] [Related]
23. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
24. Prescription practice for LH-RH analogs and androgen receptor antagonists in the treatment of advanced prostate cancer in Germany (1993-2003).
Rohde V; Diemer T; Hauck E; Bestmann B; Miller J; Schröder H; Weidner W; Katalinic A
Urol Int; 2006; 77(4):311-6. PubMed ID: 17135780
[TBL] [Abstract][Full Text] [Related]
25. A retrospective cost-analysis of additional homeopathic treatment in Germany: Long-term economic outcomes.
Ostermann JK; Witt CM; Reinhold T
PLoS One; 2017; 12(9):e0182897. PubMed ID: 28915242
[TBL] [Abstract][Full Text] [Related]
26. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
27. Societal cost of cancer in Norway -Results of taking a broader cost perspective.
Bugge C; Sæther EM; Brustugun OT; Kristiansen IS
Health Policy; 2021 Aug; 125(8):1100-1107. PubMed ID: 34088521
[TBL] [Abstract][Full Text] [Related]
28. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
29. Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysis.
Brandes A; Koerber F; Schwarzkopf L; Hunger M; Rogowski WH; Waidelich R
BMC Health Serv Res; 2016 Nov; 16(1):664. PubMed ID: 27863486
[TBL] [Abstract][Full Text] [Related]
30. Analysis of costs of transrectal prostate biopsy.
Fandella A
Urologia; 2011; 78(4):288-92. PubMed ID: 22139803
[TBL] [Abstract][Full Text] [Related]
31. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
[TBL] [Abstract][Full Text] [Related]
32. The economic burden of prostate cancer.
Roehrborn CG; Black LK
BJU Int; 2011 Sep; 108(6):806-13. PubMed ID: 21884356
[TBL] [Abstract][Full Text] [Related]
33. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
[TBL] [Abstract][Full Text] [Related]
34. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
35. Economic burden in a German cohort of patients with multiple sclerosis.
Reese JP; John A; Wienemann G; Wellek A; Sommer N; Tackenberg B; Balzer-Geldsetzer M; Dodel R
Eur Neurol; 2011; 66(6):311-21. PubMed ID: 22086151
[TBL] [Abstract][Full Text] [Related]
36. Association of costs with somatic symptom severity in patients with medically unexplained symptoms.
Konnopka A; Kaufmann C; König HH; Heider D; Wild B; Szecsenyi J; Herzog W; Heinrich S; Schaefert R
J Psychosom Res; 2013 Oct; 75(4):370-5. PubMed ID: 24119945
[TBL] [Abstract][Full Text] [Related]
37. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Duchesne GM; Woo HH; Bassett JK; Bowe SJ; D'Este C; Frydenberg M; King M; Ledwich L; Loblaw A; Malone S; Millar J; Milne R; Smith RG; Spry N; Stockler M; Syme RA; Tai KH; Turner S
Lancet Oncol; 2016 Jun; 17(6):727-737. PubMed ID: 27155740
[TBL] [Abstract][Full Text] [Related]
38. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
[TBL] [Abstract][Full Text] [Related]
39. Depression in Central and Eastern Europe: How Much It Costs? Cost of Depression in Romania.
Iordache MM; Sorici CO; Aivaz KA; Lupu EC; Dumitru A; Tocia C; Dumitru E
Healthcare (Basel); 2023 Mar; 11(6):. PubMed ID: 36981578
[TBL] [Abstract][Full Text] [Related]
40. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project.
Hallert E; Husberg M; Kalkan A; Skogh T; Bernfort L
Scand J Rheumatol; 2014; 43(3):177-83. PubMed ID: 24354438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
